Positive Lynparza readout

AstraZeneca has just announced positive Breast cancer results from a head to head Phase III trial which compares its PARP…

Compass study a success

Bayer, best known for its Aspirin brand, just reported that Xarelto met its primary MACE endpoint in the COMPASS study…

Levodopa reloaded

Acorda Therapeutics has now released results from its late-stage clinical trial of CVT-301, an oral inhaler based formulation of levodopa.…

Innate’s AML study fails

Innate Pharma, based in Marseille, France, today reported the failure of a phase II Lirilumab study in AML, called the…

Stemline reports setback

Stemline on Thursday had to report that another patient died from capillary lead syndrome (CLS) after receiving SL-401, the company’s…

TCR making progress

Adaptimmune just presented a poster at the society for Immunotherapy of Cancer annual meeting 2016 where they provide some encouraging…